Abeona Therapeutics Inc.ABEONASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank86
3Y CAGR+20.6%
5Y CAGR-0.1%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+20.6%/yr
vs -4.0%/yr prior
5Y CAGR
-0.1%/yr
Recent acceleration
Acceleration
+24.6pp
Accelerating
Percentile
P86
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $90.98M | +48.4% |
| 2024 | $61.30M | +25.0% |
| 2023 | $49.03M | -5.5% |
| 2022 | $51.88M | -44.1% |
| 2021 | $92.84M | +1.5% |
| 2020 | $91.42M | +220.5% |
| 2019 | $28.52M | -53.4% |
| 2018 | $61.16M | +113.3% |
| 2017 | $28.67M | +15.8% |
| 2016 | $24.77M | - |